A clinical trial to compare the combination of Lornoxicam and Paracetamol with Lornoxicam alone in relieving pain and other symptoms.
Phase 3
Completed
- Registration Number
- CTRI/2009/091/000056
- Lead Sponsor
- Aristo Pharmaceuticals pvt ltd Mumbai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 201
Inclusion Criteria
Patients with either sex, from 18-60 years age. Informed consent, extra articular inflammation.
Exclusion Criteria
Female pregnant or with chances of pregnancy or nursing, History of allergy or hypersensitivity. physical/clinical abnormalities, any condition which affect study of drug.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method